Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Foley

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|May 28, 2014
Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trialS Del Prato, J E Foley, W Kothny, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1985
Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniquesJ E Foley, Y D Chen, C K Lardinois, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1991
Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetesC Y Jeng, C B Hollenbeck, M S Wu, et al.
Molecular Genetics and Metabolism|March 13, 2001
Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima IndiansC Weyer, J K Wolford, R L Hanson, et al.
Diabetologia|July 4, 2006
Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetesN Matikainen, S Mänttäri, A Schweizer, et al.
Pharmacology & Toxicology|September 15, 2000
Effects of apocynin and natural antioxidant from spinach on inducible nitric oxide synthase and cyclooxygenase-2 induction in lipopolysaccharide-induced hepatic injury in ratL Lomnitski, J E Foley, S Grossman, et al.
Diabetes Care|May 26, 2001
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetesP A Hollander, S L Schwartz, M R Gatlin, et al.
Diabetes|November 1, 1990
Inhibition of hepatic glucose production by SDZ 51641D A Young, R S Ho, P A Bell, et al.
Journal of Clinical Microbiology|September 17, 1999
Isolation of Helicobacter canis from a colony of bengal cats with endemic diarrheaJ E Foley, S L Marks, L Munson, et al.
Diabetes, Obesity & Metabolism|March 22, 2008
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemiaW A Scherbaum, A Schweizer, A Mari, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Diabetic Medicine : a Journal of the British Diabetic Association|May 28, 2014
Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trialS Del Prato, J E Foley, W Kothny, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1985
Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniquesJ E Foley, Y D Chen, C K Lardinois, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1991
Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetesC Y Jeng, C B Hollenbeck, M S Wu, et al.
Molecular Genetics and Metabolism|March 13, 2001
Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima IndiansC Weyer, J K Wolford, R L Hanson, et al.
Diabetologia|July 4, 2006
Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetesN Matikainen, S Mänttäri, A Schweizer, et al.
Pharmacology & Toxicology|September 15, 2000
Effects of apocynin and natural antioxidant from spinach on inducible nitric oxide synthase and cyclooxygenase-2 induction in lipopolysaccharide-induced hepatic injury in ratL Lomnitski, J E Foley, S Grossman, et al.
Diabetes Care|May 26, 2001
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetesP A Hollander, S L Schwartz, M R Gatlin, et al.
Diabetes|November 1, 1990
Inhibition of hepatic glucose production by SDZ 51641D A Young, R S Ho, P A Bell, et al.
Journal of Clinical Microbiology|September 17, 1999
Isolation of Helicobacter canis from a colony of bengal cats with endemic diarrheaJ E Foley, S L Marks, L Munson, et al.
Diabetes, Obesity & Metabolism|March 22, 2008
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemiaW A Scherbaum, A Schweizer, A Mari, et al.
Pageof 15